Two private equity consortia submitted second-round bids on Wednesday for medical diagnostics company Beckman Coulter Inc (BEC.N), which put itself up for sale last year, two sources familiar with the situation said. Beckman hired Goldman Sachs Group Inc (GS.N) to help it weigh strategic options, including a possible sale of the company, sources told Reuters in December. The company has a market valuation of more than $5 billion. If private equity firms succeed, it would make it one of the largest leveraged buyouts since the credit crisis.
Source
